Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS +4.33%·Rev n/aQ4 21EPS +34.62%·Rev n/aQ3 21EPS -100.00%*·Rev n/aQ2 21EPS n/a·Rev n/a⚠ consensus missing

GeneDx Holdings Corp. WGS

Company Representatives — Various Executive Roles

Joel Kaufman — Vice President of Finance and Corporate Development

Katherine Stueland — Chief Executive Officer

Eric Schadt — Founder, President and Chief R&D Officer

Isaac Ro — Chief Financial Officer

+19.2%1d on move date+16.8% vs SPY3d+19.8%5d+18.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WGS calls or request research access.

More WGS calls Browse calls Request research access